Allspring Global Investments Holdings, LLC Vaxcyte, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 347,474 shares of PCVX stock, worth $29.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
347,474
Previous 343,552
1.14%
Holding current value
$29.6 Million
Previous $25.9 Million
52.93%
% of portfolio
0.06%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding PCVX
# of Institutions
358Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$976 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$932 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$848 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$741 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$418 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.06B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...